iShares Health Innovation Active ETF (BMED)

Assets	$13.42M
Expense Ratio	0.55%
PE Ratio	29.27
Shares Out	400,000
Dividend (ttm)	$0.08
Dividend Yield	0.24%
Ex-Dividend Date	Jun 15, 2026
Payout Frequency	n/a
Payout Ratio	6.98%

Volume	4,504
Open	34.24
Previous Close	34.17
Day's Range	33.86 - 34.24
52-Week Low	25.79
52-Week High	34.86
Beta	0.74
Holdings	60
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

40.98% of assets

Name	Symbol	Weight
Gilead Sciences, Inc.	GILD	5.11%
AbbVie Inc.	ABBV	4.70%
Thermo Fisher Scientific Inc.	TMO	4.34%
Moderna, Inc.	MRNA	4.30%
Johnson & Johnson	JNJ	4.29%
Edwards Lifesciences Corporation	EW	3.80%
IQVIA Holdings Inc.	IQV	3.79%
Waters Corporation	WAT	3.62%
Danaher Corporation	DHR	3.59%
Biogen Inc.	BIIB	3.45%

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 15, 2026	$0.08118	Jun 18, 2026
Dec 20, 2023	$0.00721	Dec 27, 2023

Performance

BMED had a total return of 29.23% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.88%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Sep 19, 2026

Data Sources Report a data error